CD226 and primary cutaneous T-cell non-Hodgkin lymphoma: Takahashi et al. published that in patients with cutaneous T-cell lymphoma, the decreased CD226 expression by the CD8+ and NK cell populations was accompanied by an increased CD226 serum level compared to healthy controls.